CG Kind of Date of meeting No referral iCMS RMS PT notification discussion Area of disagreement Outcome Composition / Risk 13 Formal DE UK 18 20/04/2015 CG-11&12 assessment Closed. CG agreement Identified SoCs / Risk 14 Formal DE UK 8 11/05/2015 CG-11&12 assessment Closed. CG agreement 15 Formal DK DE 1 22/06/2015 CG-12&13 Risk assessment Closed. CG agreement 23/09/2015 16 Formal DE IT 14 CG-14 Efficacy Closed. CG agreement Environmental risk Closed. Referred to Commission under 26/10/2015 17 Formal DE UK 18 CG-14, 15 assessment Art 36 BPR Phys-chem properties, efficacy and human 18/01/2016 18 Formal FR UK 8 CG-16 health risk assessment Closed. CG agreement Human health risk 18/01/2016 19 Formal FR DE 8 CG-16 assessment Closed. CG agreement 22/01/2016 20 Formal DE UK 8 CG-16 Efficacy Closed. CG agreement Human health risk 29/01/2016 21 Formal DE DK 8 CG-16 assessment Closed. CG agreement health risk 14/04/2016 22 Formal DE FR 18 CG-17 assessment Closed. CG agreement 1,2 CG- 17 & Closed. CG agreement 11/05/2016 23 Formal NL LV and 4 CG-18 Efficacy 23/05/2016 Closed. CG agreement 24 Formal FR UK 18 CG-18 Efficacy 08/06/2016 Closed. CG agreement 25 Formal DE IT 14 CG-18 RMM 22/08/2016 26 Formal FR DE 18 CG-19 Efficacy Under discussion 22/08/2016 27 Formal FR DE 18 CG-19 Efficacy Under discussion
No Kind of referral iCMS RMS PT Date of notification CG meeting discussion Area of disagreement Outcome 13 Formal DE UK 18 20/04/2015 CG-11&12 Composition / Risk assessment Closed. CG agreement 14 Formal DE UK 8 11/05/2015 CG-11&12 Identified SoCs / Risk assessment Closed. CG agreement 15 Formal DK DE 1 22/06/2015 CG-12&13 Risk assessment Closed. CG agreement 16 Formal DE IT 14 23/09/2015 CG-14 Efficacy Closed. CG agreement 17 Formal DE UK 18 26/10/2015 CG-14, 15 Environmental risk assessment Closed. Referred to Commission under Art 36 BPR 18 Formal FR UK 8 18/01/2016 CG-16 Phys-chem properties, efficacy and human health risk assessment Closed. CG agreement 19 Formal FR DE 8 18/01/2016 CG-16 Human health risk assessment Closed. CG agreement 20 Formal DE UK 8 22/01/2016 CG-16 Efficacy Closed. CG agreement 21 Formal DE DK 8 29/01/2016 CG-16 Human health risk assessment Closed. CG agreement 22 Formal DE FR 18 14/04/2016 CG-17 health risk assessment Closed. CG agreement 23 Formal NL LV 1,2 and 4 11/05/2016 CG- 17 & CG-18 Efficacy Closed. CG agreement 24 Formal FR UK 18 23/05/2016 CG-18 Efficacy Closed. CG agreement 25 Formal DE IT 14 08/06/2016 CG-18 RMM Closed. CG agreement 26 Formal FR DE 18 22/08/2016 CG-19 Efficacy Under discussion 27 Formal FR DE 18 22/08/2016 CG-19 Efficacy Under discussion
CA-Sept16-Doc.4.7-%20Overview%20referrals.docx